AMSCI Projects
Oxford BioMedica
Location: Oxford
Status: Completed
Area: 1,925 sqm
As part of a £13m Advanced Manufacturing Supply Chain Initiative (AMSCI)-funded expansion of research and manufacturing facilities, Oxford BioMedica appointed Abell Nepp for two gene therapy manufacturing facilities including the design fit-out of two suites of GMP ISO 5, Class 100 clean rooms.
Design Team:
Abell Nepp (Architect|Lead Consultant), Biopharm (Bio-process Planning), Glanville Group (Structural), GMP Group (MEP), Porta Planning (Town Planning), Thomas & Adamson (PM), Walter Lilly|WH Partnership (Contractors)
Abell Nepp (Architect|Lead Consultant), Biopharm (Bio-process Planning), Glanville Group (Structural), GMP Group (MEP), Porta Planning (Town Planning), Thomas & Adamson (PM), Walter Lilly|WH Partnership (Contractors)